Launch of Lipid Modification
Published: 09 June 2000
The National Institute for Health and Clinical Excellence (NICE) and the National Collaborating Centre for Primary Care (NCC PC) have issued new guidance to the NHS in England and Wales on the identification of people at risk of cardiovascular disease (CVD) and on the use of lipid lowering drugs to reduce that risk.
Download the full press release (pdf 37KB)

